HAE (Haemonetics Corp) Company Net Income

Official company branding of haemonetics.com (HAE)

Haemonetics Corporation (HAE) net profitability reflects the demand dynamics for plasma-replacement technologies and consumables. This trend is supported by patent protection for equipment and a complex certification process. Profit growth is further driven by laboratory automation and the expansion of the hematology market. The value of 0.10 captures the current state of the parameter, allowing for a real-time assessment of the company's daily revenue and expense balance.

Haemonetics Corp (HAE) Net Income: for the period 07/04/2022 - 10/30/2026

Financial and market metric breakdowns for Haemonetics (HAE)

- current price and projected stock value:
Quote Chart Haemonetics Company|HAE - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Haemonetics Company|HAE - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share Haemonetics|HAE - Company Net Assets|Market Cap to Book Value Multiple haemonetics.com|HAE - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Haemonetics Corporation|HAE - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Haemonetics Corp|HAE - Company Total Debt|Debt to Net Assets Ratio Haemonetics Company|HAE - Company Long-Term Debt|Company Current Liabilities Haemonetics|Immediate Liquidity haemonetics.com
- earnings and market multiples details:
HAE - Net Profit
Summary company analysis:Haemonetics Company (HAE)
Mass-produced product of Haemonetics Corp.

Stable net income confirms the long-term reliability of Haemonetics Corporation (HAE), while the company's operating results capture daily financial trends to identify sustainable price corridors. A breakout of the curve beyond these range boundaries signals fundamental shifts, reflecting the efficiency of deploying high-margin plasma collection systems and surgical hemostasis devices within the business's revenue structure.

Main competitors

Profit After Tax DXCM (Dexcom CGM)|PEN (Penumbra, Inc.) - Net Profit|Company Net Income novanta.com NOVT|Net Income INSP (Inspire Medical Systems, Inc.)|Net Profit PROCEPT BioRobotics Corp (PRCT)|CONMED Corp. - Net Income|Profit After Payment of Taxes PLSE (Pulse Medical)|InMode Ltd. - Net Profit|Net Financial Result picardmedical.com PMI|SRDX: Net Profit|Net Income Eversense|Net Income NPCE|TCMD: Final Profit|Company Net Income Sanuwave Health Inc (SNWV)|Net Income outsetmedical.com OM|Net Profit ELMD (Electromed)|LENSAR Inc. (LNSR) - Company Net Income|AVITA Medical, Inc - Net Profit|PROF (Profound Medical Corp.) - Company Profit|BDMD: Net Profit|EDAP - Net Financial Result|APYX (Apyx Medical Corp) - Net Profit|Net Income IceCure Medical, Ltd. (ICCM)|Net Profit LUNG|Net Profit telabio.com (TELA)|Company Net Income CytoSorbents Corporation CTSO|sensushealthcare.com - Company Net Income|ZYXI: Net Income|Final Profit ECOR (electroCore, Inc.)|RBOT: Net Profit|Company Net Income Inspira Technologies (IINN)|Company Net Income SeaStar Medical Holding|IRIX - Annual Net Income|Net Income INBS (Intelligent Bio Solutions)|Net Profit beyondair.net (XAIR)|Net Profit PFSA (Profusa, Inc.)|Net Financial Result STRATA Skin Sciences Inc. (SSKN)|GCTK - Company Net Income|Profit After Tax NAOV|Venus Concept (VERO) - Company Net Income|Net Income Nuwellis Inc|AEMD (Aethlon) - Net Profit|Company Net Income TransEnterix ASXC|Company Net Income Avinger, Inc. (AVGR)|BioSig - Company Profit|Cutera - Net Income|Profit After Payment of Taxes KNW (Know Labs Inc)|Inari - Net Profit|Final Profit NVRO (Nevro Medical)|RSLS: Net Profit|silkroadmed.com (SILK) - Net Profit